AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cancer Uterus Cervix

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Intra-lesional Tumor Boost for Bulky Cervical Cancer NCT07435376Phase 21 site📍 Seongnam-si Seoul National University Bundang Hospital · Tests: intra-lesional boost IMRT, High Dose Rate Brachytherapy Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study. NCT07400809n/a1 site📍 Mumbai Tata Memorial Hospital · Tests: Not applicable- observational study Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix NCT04723095n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Follow-Up, Medical Chart Review MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy) NCT06041555n/a1 site📍 Lyon Hospices Civils de Lyon · Tests: 3 MRI sequences (T2*, IVIM and Multi Echo-Gradient), without injection, are performed Screening Triage and Risk Stratification NCT05727228n/a1 site📍 Randers University of Aarhus · Tests: cytology, p16/ki67 dual stain cytology (DS), extended genotyping, DNA methylation, viral load, A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV) NCT05334706Phase 41 site📍 L'Hospitalet de Llobregat Miquel Angel Pavon Ribas · Tests: Nonavalent HPV vaccine (9vHPV/Gardasil-9™). Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix) NCT06266338Phase 21 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Pembrolizumab, Lenvatinib A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer NCT07305727n/a1 site📍 Nîmes Centre Hospitalier Universitaire de Nīmes Plan of the Day Radiotherapy NCT05634681NA1 site📍 Oslo Oslo University Hospital · Tests: Plan of the day, Standard plan Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer NCT03010150n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Questionnaire Administration Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer NCT06416748NA1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Minimally invasive simple hysterectomy Clinical Response and Toxicity of Hypo-fractionated Chemoradiotherapy in Cervix Cancer NCT04831437Phase 21 site📍 Tehran Tehran University of Medical Sciences · Tests: Hypofractionated EBRT, Standard EBRT Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies NCT07292818Phase 11 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Barrigel gel spacer Thermal Artifact in Patients Undergoing Conization: A Clinical Study NCT07372248NA1 site📍 Adana Saglik Bilimleri Universitesi · Tests: Conization with Electrosurgery diffferent power settings Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer NCT06196190n/a1 site📍 Haifa Rambam Health Care Campus Multimodality Treatments of HPV-related Lesions of the Female Genital Tract NCT05938192n/a1 site📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Tests: vaccination Conservative Management of HSIL in Patients With Future Pregnancy Aspiration NCT04783805n/a1 site📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: Conservative management with regular follow-up, Conization Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study NCT07435623n/a1 site📍 Mumbai Tata Memorial Hospital Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue NCT07040657NA2 sites📍 Ankara📍 Izmir Dokuz Eylul University · Tests: Sentinel Lymph Node Detection/Cervical Methylene Blue Injection Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease NCT03101995Phase 21 site📍 Mexico City National Institute of Cancerología · Tests: Gemcitabine A Study of Lorigerlimab in Participants With Advanced Solid Tumors NCT06730347Phase 216 sites📍 Los Angeles📍 New Orleans📍 Grand Rapids MacroGenics · Tests: Lorigerlimab Respiration After Robot Assisted Laparoscopic Hysterectomy NCT06806280n/a1 site📍 Gothenburg Göteborg University Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer NCT07480902NA1 site📍 Mexico City Timser SAPI de CV · Tests: Physical examination, Liquid-based cytology, Molecular screening, HPV DNA test, Colposcopy A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer NCT04831580NA156 sites📍 Goodyear📍 Duarte📍 Encinitas GOG Foundation · Tests: da Vinci, open surgery Building Connections NCT07091032NA1 site📍 Boston Massachusetts General Hospital · Tests: Treatment as Usual, Building Connections Intervention PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer NCT06157151Phase 23 sites📍 Little Rock📍 Bethesda📍 Seattle Precigen, Inc · Tests: PRGN-2009 plus Pembrolizumab Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS) NCT06116019n/a1 site📍 Berlin Charite University, Berlin, Germany · Tests: Online adaptive radiation therapy Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" NCT01365169NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Exercise Intervention, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer NCT06147960n/a1 site📍 Nîmes Centre Hospitalier Universitaire de Nīmes · Tests: Immunohistochemistry
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy